Senior Manager, Legal, PwC Switzerland
She’s a team member of the Asset & Wealth Management and Banking Regulatory team with a strong focus on asset and wealth management, in particular asset management regulatory topics and with extensive experience with clients in asset and wealth management on regulatory and regulatory-related topics, in particular topics in relation to FINMA regulation.
Barbara’s been working in the area of financial market regulation for more than 15 years and has been working with PwC Switzerland for about four years. Prior to joining PwC, she worked at a major law firm advising financial intermediaries, banks and similar on regulatory topics, a Swiss bank and a financial intermediary. She’s admitted to the Swiss bars and is fluent in German and English, and also speaks French and Chinese.
Discover how pharma and life sciences companies can build resilient, adaptable operating models to navigate geopolitical risks and unlock new opportunities.
Liechtenstein Financial Services Podcast: A conversation with Sebastian Gutmann about IFRS 18, the new standard for presentation and disclosures in financial...
Explore how AI is transforming batch release in pharma — enhancing speed, safety and compliance with GxP, MHRA, EMA and data protection standards.
Health industries M&A activity declined in the first half of 2025 compared to the prior year, as dealmakers faced mounting headwinds. While the year began with...